Compare Bio Protocol (BIO) vs Cudis (CUDIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Cudis — how do they compare? Bio Protocol trades at Rp513.25 (market cap Rp1,15T, Rp260,42M 24h volume), while Cudis trades at Rp87.33 (market cap Rp21,88M, Rp81,53M 24h volume). The key difference: Bio Protocol is far larger — about 52559.4× Cudis's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 247,5M / 1B CUDIS (25%) for Cudis. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Cudis for 11 Days on average.
| BIO | CUDIS | |
|---|---|---|
Market Cap | Rp1,15T | Rp21,88M |
Volume (24h) | Rp260,42M | Rp81,53M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 247,5M / 1B CUDIS (25%) |
Typical Hold Time | 16 Days | 11 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Cudis is trading at Rp87.293 with a market cap of Rp21.8M, showing a bearish technical outlook as moving averages signal strong selling pressure and oscillators remain neutral. The asset is near resistance at Rp86 with support at Rp80, while RSI_6 at 13.35 indicates potential oversold conditions. No recent protocol updates or ecosystem developments have been noted, and the token's circulating supply is 247.5M out of a 1B max supply, with a 25% circulation rate.
Overall, the outlook is cautious due to bearish signals and low liquidity, but the oversold RSI may present a short-term opportunity. Major risks include high volatility, limited exchange depth, and regulatory uncertainty in crypto markets. Investors should monitor for any network activity shifts or exchange listings that could impact price dynamics.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Cudis
CUDIS is creating the first-ever Longevity Protocol aimed at making longevity trackable, personalized, and rewarding. By integrating the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users will have complete ownership of their health data, receive real-time insights on their longevity, and gain economic incentives for optimizing their biological health. CUDIS is building a new ecosystem for longevity that includes realistic and effective products, programs, and services, in collaboration with partners around the world.
Read more on CUDIS →
